Best Medical Equipment Grants in Wyoming

The Clarence W. Winter Charitable Trust, established from Mr. Winter's Will, provides annual grants of $3,000 to $5,000 to support tax-exempt organizations focused on charitable, religious, scientific, literary, or educational purposes. While there are no geographic restrictions, the Trust prioritizes organizations in Bucks County, PA. With a commitment to community betterment, Mr. Winter's legacy continues to support impactful initiatives for years to come.

The Tuttleman Foundation, established in Philadelphia in 2003, provides grants ranging from $1,000 to $250,000 to 501c3 organizations. Guided by the legacy of Stanley and Edna Tuttleman, the foundation focuses on areas such as education, community building, health care, arts and museums, basic human services, and spirituality. Their engaged philanthropy aims to support enduring benefits for the communities they serve, reflecting the founders' commitment to impactful giving.

The HEAL Initiative aims to address the complex interplay between chronic pain and opioid use disorder (OUD), affecting 40-60% of OUD patients. Through the IMPOWR initiative, this funding opportunity seeks to develop integrated care strategies that enhance treatment delivery at health systems levels. By identifying effective interventions and collaborative care models, the initiative strives to improve patient outcomes in managing both chronic pain and OUD, while emphasizing the roles of various healthcare professionals in this integrated approach.

The Larry H. & Gail Miller Family Foundation offers General Operating Grants aimed at 501(c)(3) nonprofits that serve the west side of Salt Lake City. Grants of up to $10,000, with an average of $5,000, support initiatives in health, shelter, education, economic self-reliance, and cultural enrichment. Applications are reviewed monthly. Organizations must be registered as nonprofits and align with the Foundation's focus areas to be eligible for funding.

The Musicians Foundation Grant provides financial assistance to professional musicians in need, covering medical and dental bills, living expenses, and other essential costs during emergencies. Applicants must demonstrate at least five years of professional experience and apply for reasons beyond loss of work. The grants are issued as vendorized checks to ensure immediate support. This program is not designed for COVID-19 assistance or general income support, focusing instead on urgent hardship cases.

The Peyronie's Disease Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients suffering from Peyronie's disease. This condition involves the formation of fibrous scar tissue in the penis, leading to painful erections and erectile dysfunction. The fund provides financial assistance for prescription drugs and related healthcare costs, ensuring that patients receive necessary treatment without the stress of high out-of-pocket expenses. HealthWell is committed to improving access to essential healthcare for America’s underinsured population.

The Waldenstrom Macroglobulinemia Fund provides crucial financial assistance to underinsured patients suffering from this rare blood cancer. Through the HealthWell Foundation, the fund helps cover prescription copays, insurance premiums, and treatment-related costs, ensuring access to necessary medical care. With over $1.2 billion in grants awarded, the program has supported more than 1.1 million patients since its inception in 2004. Its mission is to alleviate financial barriers to essential healthcare, allowing patients to focus on their treatment and recovery.

The Systemic Sclerosis with Interstitial Lung Disease Fund, managed by the HealthWell Foundation, aims to reduce financial barriers for underinsured patients suffering from systemic sclerosis. This rare autoimmune disease leads to excessive collagen production, causing serious health issues. The fund assists with prescription copays and insurance premiums to ensure patients receive necessary treatments. In 2024, HealthWell awarded over $1.2 billion in grants, supporting more than 1.1 million patients in accessing vital healthcare services.

The Porphyrias Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients suffering from porphyrias, a group of eight disorders characterized by the accumulation of porphyrins in the body. The fund assists with prescription drug copays and insurance premiums, offering up to $4,000 in financial aid. Established to ensure no patient lacks necessary treatment due to costs, the foundation has awarded over $1.2 billion since 2004, supporting more than 1.1 million patients.

The Metabolic Dysfunction-Associated Steatohepatitis Fund, established by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients facing chronic illnesses. It provides critical support for expenses related to prescription copays, insurance premiums, and transportation for treatment. With a maximum award of $8,000, the fund ensures that individuals can access necessary healthcare services without financial strain. This initiative emphasizes the commitment to improving health outcomes for those affected by metabolic dysfunction-associated steatohepatitis.

The Mantle Cell Lymphoma Fund, managed by the HealthWell Foundation, provides financial assistance to underinsured patients diagnosed with Mantle Cell Lymphoma. The fund covers prescription drug copays and Medicare Part B premiums, with a maximum award of $8,500. Eligible patients must have insurance that covers their medication and meet specific income guidelines. The foundation aims to reduce financial barriers to essential treatments, ensuring that patients receive necessary care without undue financial strain.

The HealthWell Foundation's Inborn Metabolic or Genetic Bile Acid Deficiency Vitamins and Supplements Fund provides essential financial assistance for individuals facing significant health challenges. By covering copays, deductibles, and related expenses, the fund aims to alleviate the financial burden on underinsured patients. With a commitment to enhancing healthcare access, the Foundation has awarded over $1.2 billion since its inception, ensuring that vital treatments remain accessible to those in need.

The Hyperoxaluria Fund, managed by the HealthWell Foundation, aims to alleviate financial burdens for underinsured patients suffering from hyperoxaluria, a condition characterized by excessive oxalate in urine. This fund assists with prescription drug copays and insurance premiums, providing vital support for treatments. In 2024 alone, HealthWell allocated over $1.2 billion in grants, ensuring access to essential medications for those in need. The organization is committed to improving healthcare access and reducing disparities for affected individuals.

The Emergency/Medical Workers Behavioral Health Fund aims to support emergency workers facing trauma and anxiety due to their roles. Established by the HealthWell Foundation, it provides financial assistance for treatment-related costs, including copayments for prescription drugs, counseling, and transportation. In 2024, the Foundation awarded over $1.2 billion to underinsured patients, ensuring no one is denied essential healthcare due to financial barriers. This initiative helps address the critical mental health needs of those who serve on the front lines.

Individuals in Wyoming receiving treatment for Dupuytren’s disease can get help covering prescription drug copays and Medicare Part B premiums through this HealthWell Foundation fund, with awards up to US $3,500. Grants support access to covered medications and related treatments delivered within the U.S. for underinsured patients meeting income and insurance guidelines.

Patients in Wyoming and nationwide being treated for Cushing’s disease or Cushing’s syndrome who are underinsured can receive up to US $10,000 to cover prescription drug copays and Medicare Part B premiums. Focused on health care access, Healthwell Foundation invites eligible individuals receiving treatment in the U.S. to apply for this financial assistance.

Individuals in Wyoming with congenital sucrase-isomaltase deficiency can receive up to US $10,000 to offset prescription drug copays and Medicare Part B premiums. Focused on health care access, Healthwell Foundation supports underinsured patients in the U.S., which may help those facing high costs for CSID-related treatments and medications.

Individuals in Wyoming and across the U.S. being treated for chronic lymphocytic leukemia with insurance coverage can apply for the Healthwell Foundation’s Chronic Lymphocytic Leukemia Fund; awards up to US $8,000 for prescription drug copays and Medicare Part B premiums. Support may ease costs tied to accessing necessary cancer care.

Individuals receiving cancer-related behavioral health treatment in Wyoming can receive up to US $2,000 to help cover prescription copays, counseling, psychotherapy, cognitive behavioral therapy, and transportation costs. The Healthwell Foundation supports U.S. patients who are underinsured and meet medical, insurance, and income guidelines through its Cancer-Related Behavioral Health Fund.

Individuals in Wyoming receiving treatment for blepharitis can get help covering prescription drug copays and certain insurance premiums through the HealthWell Foundation, with awards up to US $3,500. Grants from HealthWell Foundation help patients access needed eye disease medications and related health care costs when they are underinsured and meet income and treatment criteria.

Wyoming patients with ANCA-associated vasculitis or granulomatosis with polyangiitis who are underinsured can receive up to US $6,000 to cover prescription drug copays and Medicare Part B premiums. Wyoming residents meeting Healthwell Foundation’s medical, insurance, and income guidelines may be eligible for this U.S.-wide health care access support.

Individuals in Wyoming being treated for amyotrophic lateral sclerosis and facing out-of-pocket prescription or Medicare Part B premium costs can receive up to US $15,000 for covered ALS medications. Grants from HealthWell Foundation help underinsured patients in the U.S. reduce financial barriers to essential ALS treatments and related care expenses.

Wyoming patients with amyloidosis who are underinsured and have qualifying health coverage can receive up to US $8,000 for prescription drug copays and Medicare Part B premiums. The Healthwell Foundation’s Amyloidosis Fund supports U.S.-based treatment costs for covered medications when income falls within its federal poverty level guidelines.

Patients with Alagille syndrome receiving treatment in Wyoming and elsewhere in the U.S. can get up to US $1,500 to offset copays for prescribed vitamins, supplements, and related formulas. Grants from HealthWell Foundation help underinsured individuals manage out-of-pocket costs, which may ease financial strain for families navigating specialized care and equipment needs.

The Pharmacy Leadership Scholars program, offered by the ASHP Research and Education Foundation, is a competitive grant initiative aimed at early-stage pharmacist researchers focusing on diversity, equity, and inclusion (DEI) in healthcare. With funding of up to five $10,000 grants, this program fosters collaboration and leadership development among grantees. It encourages innovative research addressing DEI gaps, aiming to empower pharmacists to enhance healthcare access and quality for diverse populations. This initiative is pivotal for shaping future leaders in pharmacy.

The MOORE Equity in Mental Health Community Grants Program, initiated by the American Psychiatric Association Foundation, aims to enhance mental health services for young people of color. With grants up to $10,000 over two years, it supports community organizations addressing mental health and substance use inequities. Eligible applicants include non-profits with a focus on culturally relevant care and sustainable solutions. The program fosters collaboration and awareness through innovative initiatives aimed at improving access to essential mental health services.

The AbbVie Foundation Health Equity Accelerator seeks innovative solutions to enhance healthcare access for underserved communities. This program empowers nonprofit organizations by providing mentorship, resources, and financial support, including a $10,000 stipend for participants and a $50,000 grant for the best solution. By fostering community-led initiatives, the accelerator aims to address health disparities and improve the quality of care through tailored, grassroots approaches. Applications are encouraged from organizations rethinking care delivery models.